Results 231 to 240 of about 7,556 (242)

Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study. [PDF]

open access: yesNat Commun
Koester A   +19 more
europepmc   +1 more source

A Novel Dual-Fc Bispecific Antibody with Enhanced Fc Effector Function. [PDF]

open access: yesBiochemistry
Zhou F   +10 more
europepmc   +1 more source

Efanesoctocog alfa: the renaissance of Factor VIII replacement therapy.

open access: yesHaematologica
Dargaud Y   +3 more
europepmc   +1 more source

Production and characterization of human soluble CD83 fused with the fragment crystallizable region of human IgG1 in Pichia pastoris

open access: closedApplied Microbiology and Biotechnology, 2013
The cell surface protein CD83 belongs to the immunoglobulin superfamily and is highly expressed on mature dendritic cells. The soluble form of CD83, sCD83, is a potential immune suppressor. In a previous study, recombinant soluble CD83 was expressed in Escherichia coli, resulting in a lack of functional glycosylation.
Yuan, Y.   +9 more
openaire   +5 more sources

3.5 Elevated Levels of Both Membrane-Bound and Soluble Forms of a Receptor Specific for the Fragment Crystallizable Region of Immunoglobulin M in Patients with CLL

open access: closedClinical Lymphoma Myeloma and Leukemia, 2011
3.5 Elevated Levels of Both Membrane-Bound and Soluble Forms of a Receptor Specific for the Fragment Crystallizable Region of Immunoglobulin M in Patients with CLL Fu Jun Li, Yoshiki Kubagawa, Matthew K. McCollum, Landon Wilson, Tomoko Motohashi, Luigi F. Bertoli, James C. Barton, Stephen Barnes, Randall S.
Fu Jun Li   +9 more
openaire   +3 more sources

Expression, purification, crystallization of fragments from the C-terminal region of DFF45/ICAD

open access: closed, 2003
Haitao Ding   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy